WOONSOCKET, R.I., 2018-Mar-08 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (March 6, 2018) that the company has expanded its safe medication disposal program inside select CVS Pharmacy locations in Rhode Island to help facilitate proper and timely disposal of opioids and other medications that could be diverted or misused if left in people's homes.…
WOONSOCKET, R.I., 2017-Nov-10 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (November 9, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all of the 77 CVS Pharmacy locations in Oklahoma, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to patients…
WOONSOCKET, R.I., 2017-Nov-10 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (November 9, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all of the nearly 300 CVS Pharmacy locations in Michigan, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to…
WOONSOCKET, R.I., 2017-Nov-10 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (Nov. 9, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at the 20 CVS Pharmacy locations in Delaware, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to patients without an…
WOONSOCKET, R.I., 2017-Jul-28 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today ( July 27, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all CVS Pharmacy locations in South Dakota. Under a collaborative practice agreement between CVS Pharmacists and a local physician, CVS pharmacies, located inside Target…
DES MOINES, Iowa, 2017-Mar-31 — /EPR Retail News/ — Today (March 29, 2017), CVS Health officials (NYSE: CVS) joined Iowa Lt. Gov. Kim Reynolds, Department of Public Health Director Gerd Clabaugh and Office of Drug Control Policy Director Steve Lukan in announcing the availability of the opioid overdose-reversal medicine naloxone without a prescription at all…
WOONSOCKET, R.I., , 2016-Dec-19 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (December 14, 2016) that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations in Nevada. CVS Health has established a standing order with physicians in Nevada that allows CVS Pharmacy to expand access to…
WOONSOCKET, R.I., 2016-Oct-03 — /EPR Retail News/ — CVS Health (NYSE: CVS) today (September 29, 2016) announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West Virginia, allowing CVS Pharmacy patients to access the medication without an individual prescription. In total, CVS Pharmacy patients in 36 states now…
WOONSOCKET, R.I., 2016-Sep-15 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (Sept. 14, 2016) that the opioid overdose-reversal medication naloxone is now available for patients without a prescription at all CVS Pharmacy locations in Washington. Under a collaborative agreement with a physician in the state, CVS pharmacists can exercise prescriptive authority to dispense…
WOONSOCKET, R.I., 2016-May-25 — /EPR Retail News/ — CVS Health (NYSE: CVS) today announced it will expand access to the opioid overdose-reversal drug naloxone in seven additional states this summer, contributing to a total of 30 states where the life-saving medication will be more accessible to CVS Pharmacy patients. CVS Health's naloxone program establishes a standing…